Publications
Antibody response to SARS-CoV-2 in people living with HIV.
Yamamoto, S., Saito, M., Nagai, E., Toriuchi, K., Nagai, H., Yotsuyanagi, H., Nakagama, Y., Kido, Y., & Adachi, E. (2021). Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi, 54(1), 144-146.
Optimal design for phase 2 studies of SARS-CoV-2 antiviral drugs
Watson, J., Kissler, S., Day, N., Grad, Y., & White, N. (2021).
The human microbiome and COVID-19: A systematic review.
Yamamoto, S., Saito, M., Tamura, A., Prawisuda, D., Mizutani, T., & Yotsuyanagi, H. (2021). PloS One, 16(6), e0253293.
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions.
Schilling, W., Callery, J., Chandna, A., Hamers, R., Watson, J., & White, N. (2021). Wellcome Open Research, 6, 71.
The WHO guideline on drugs to prevent COVID-19: small numbers- big conclusions.
Schilling, W., Callery, J., Chandna, A., Hamers, R., Watson, J., & White, N. (2021). Wellcome Open Research, 6, 71.
Comparison of Rapid Antigen Tests for COVID-19.
Yamayoshi, S., Sakai-Tagawa, Y., Koga, M., Akasaka, O., Nakachi, I., Koh, H., Maeda, K., Adachi, E., Saito, M., Nagai, H., Ikeuchi, K., Ogura, T., Baba, R., Fujita, K., Fukui, T., Ito, F., Hattori, S.-I., Yamamoto, K., Nakamoto, T., … Kawaoka, Y. (2020). Viruses, 12(12), E1420.
Convalescent plasma transfusion therapy in severe COVID-19 patients- a safety, efficacy and dose response study: A structured summary of a study protocol of a phase II randomized controlled trial
Chowdhury, F., Hoque, A., Chowdhury, F., Amin, M., Rahim, A., Rahman, M., Yasmin, R., Amin, M., Miah, M., Kalam, M., & Rahman, M. (2020). Trials, 21(1), 883.
Correction: COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
PLOS Medicine Staff. (2020). PLoS Medicine, 17(10), e1003445.
Chloroquine/ hydroxychloroquine prevention of coronavirus disease (COVID-19) in the healthcare setting; protocol for a randomised, placebo-controlled prophylaxis study (COPCOV)
Schilling, W., Callery, J., Taylor, W., Mukaka, M., Ekkapongpisit, M., Watson, J., Chandna, A., Panapipat, S., Tubprasert, J., Yuentrakul, P., Waithira, N., Cope, T., Dhorda, M., Cruz, C., von Seidlein, L., Milton, J., LLewelyn, M., Adler, A., Chotivanich, K., … White, N. (2020). Wellcome Open Research, 5, 241-241.
Effect of hydroxychloroquine in hospitalized patients with COVID-19
Horby, P., Mafham, M., Linsell, L., Bell, J., Staplin, N., Emberson, J., Tarning, J., Watson, J., White, N., Juszczak, E., Haynes, R., & Landray, M. (2020). New England Journal of Medicine, 383(21), 2030-2040.
Relative Bradycardia in Patients with Mild-to-Moderate Coronavirus Disease, Japan.
Ikeuchi, K., Saito, M., Yamamoto, S., Nagai, H., & Adachi, E. (2020). Emerging Infectious Diseases, 26(10), 2504-2506.
Infiltrative Shadows in COVID-19: Pneumonia or Pulmonary Embolism?
Nagai, H., Yamamoto, S., Saito, M., & Adachi, E. (2020). Internal Medicine (Tokyo, Japan), 59(19), 2443-2444.
Non-malarial febrile illness: a systematic review of published aetiological studies and case reports from Southern Asia and South-eastern Asia, 1980-2015
Shrestha, P., Dahal, P., Ogbonnaa-Njoku, C., Das, D., Stepniewska, K., Thomas, N., Hopkins, H., Crump, J., Bell, D., Newton, P., Ashley, E., & Guérin, P. (2020). BMC Medicine, 18.
COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology
White, N., Watson, J., Hoglund, R., Chan, X., Cheah, P., & Tarning, J. (2020). PLOS Medicine, 17(9).
Drug treatments for covid-19: living systematic review and network meta-analysis.
Siemieniuk, R., Bartoszko, J., Ge, L., Zeraatkar, D., Izcovich, A., Kum, E., Pardo-Hernandez, H., Qasim, A., Martinez, J., Rochwerg, B., Lamontagne, F., Han, M., Liu, Q., Agarwal, A., Agoritsas, T., Chu, D., Couban, R., Cusano, E., Darzi, A., … Brignardello-Petersen, R. (2020). BMJ (Clinical Research Ed.), 370, m2980 - m2980.
Gargle Lavage as a Safe and Sensitive Alternative to Swab Samples to Diagnose COVID-19: A Case Report in Japan.
Saito, M., Adachi, E., Yamayoshi, S., Koga, M., Iwatsuki-Horimoto, K., Kawaoka, Y., & Yotsuyanagi, H. (2020). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America, 71(15), 893-894.
Cases of coronavirus disease-2019 in HIV-infected transgender women.
Adachi, E., Saito, M., Ikeuchi, K., Hoshina, T., & Yotsuyanagi, H. (2020). AIDS (London, England), 34(9), 1435-1436.
Lessons from COVID-19 to future evidence synthesis efforts: first living search strategy and out of date scientific publishing and indexing industry (submitted).
Shokraneh, F., & Russell-Rose, T. (2020). Journal of Clinical Epidemiology, 123, 171-173.
Identification of Falsified Chloroquine Tablets in Africa at the Time of the COVID-19 Pandemic.
Gnegel, G., Hauk, C., Neci, R., Mutombo, G., Nyaah, F., Wistuba, D., Häfele-Abah, C., & Heide, L. (2020). The American Journal of Tropical Medicine and Hygiene, 103(1), 73-76.
Baseline results of a living systematic review for COVID-19 clinical trial registrations
Maguire, B., McLean, A., Rashan, S., Antonio, E., Bagaria, J., Bentounsi, Z., Brack, M., Caldwell, F., Carrara, V., Citarella, B., Dahal, P., Feteh, V., Guérin, M., Kennon, K., Bilton Lahaut, K., Makuka, G., Ngu, R., Obiesie, S., Richmond, C., … Guérin, P. (2020). Wellcome Open Research, 5.
COVID-19 and risks to the supply and quality of tests, drugs, and vaccines
Newton, P., Bond, K., & 53 signatories from 20 countries. (2020). Lancet Global Health .
A living systematic review protocol for COVID-19 clinical trial registrations
Maguire, B., & Guerin, P. (2020). Wellcome Open Research, 5.
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
Guerin, P., Singh-Phulgenda, S., & Strub-Wourgaft, N. (2020). F1000Research.
The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
Guerin, P., Singh-Phulgenda, S., & Strub-Wourgaft, N. (2020). F1000Research, 9.
Keeping up with studies on covid-19: systematic search strategies and resources.
Shokraneh, F. (2020). BMJ (Clinical Research Ed.), 369, m1601.